EZH2 and neoplasm: Such treatment induces transcriptional reprogramming, which is evidenced by EMT suppression, protein mutant p53 (usually detected within tumor cells), ZEB1 and EZH2 promotion, and induce E-cadherin expression, H3 trimethylation, and apoptosis.